UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Tenax Therapeutics, Inc. (Name of Issuer) Common stock (Title of Class of Securities) 88032L209 (CUSIP Number) Ziyad Binsalamah 2806-1850 Old Main Street Houston, Texas, 77030, USA (Name, Address of Person Authorized to Receive Notices and Communications) 5/18/2020 (Date of Event which Requires Filing of this Statement) CUSIP No. 88032L209 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Ziyad Binsalamah 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] 3 SEC USE ONLY 4 SOURCE OF FUNDS (See Instructions) PF 5 DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) [ ] 6 CITIZENSHIP OR PLACE OF ORGANIZATION Saudi Arabia NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 470000 8 SHARED VOTING POWER 470000 9 SOLE DISPOSITIVE POWER 470000 10 SHARED DISPOSITIVE POWER 470000 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 470000 12 THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.1% 14 TYPE OF REPORTING PERSON (See Instructions) IN Item 1. Security and Issuer (a) Name of Issuer Tenax Therapeutics, Inc. (b) Address of Issuer's Principal Executive Offices One Copley Parkway, Suite 490 Morrisville, North Carolina 27560 United States of America Item 2. Identity and Background (a) This statement on Schedule 13D is filed by Ziyad Binsalamah; an individual legal resident of the state of Texas (b) Address 2806-1850 Old Main Street, Houston, TX, 77030 (c) The Reporting Person is an individual investor (d) The reporting person has not, during the last five years, been convicted in a criminal proceeding (e) The reporting person has not, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws (f) The reporting person is a citizen of Saudi Arabia Item 3. Source or Amount of Funds or Other Consideration A total amount of approximately $430,000.00 was paid to acquire the Shares reported as beneficially owned by the Reporting Person. The funds used to purchase these securities personal funds. All Shares were purchased in the open market Item 4. Purpose of Transaction The Reporting Person purchased the Shares reported herein as a passive investor based on the Reporting Person belief that such securities represented an attractive opportunity. Depending on overall market conditions, other investment opportunities available to the Reporting Person, and the availability of securities of the Issuer prices that would make the purchase or sale of such securities desirable, the Reporting Person may endeavor to (i) increase or decrease his position in the Issuer through , among other things, the purchase or sale of securities of the Issuer on the open market or in private transactions or otherwise on such items and at such times as the Reporting Person may deem advisable and/or (ii) enter into transaction that increase or hedge the Reporting Person economic exposure to the Shares without affecting the Reporting Person beneficial ownership of shares. The Reporting person has no plans to interfere with the Issuers plan or operations. Item 5. Interest in Securities of the Issuer (a) The aggregate percentage of shares reported owned by the Reporting Person is based on 9,218,556.00 Shares outstanding, which is the total number of Shares outstanding as reported in the 10-Q report on May 15, 2020 As of May 18, 2020, Ziyad Binsalamah beneficially owns 470000 or 5.1% of the outstanding Shares. All Shares are held by the Reporting Person. The Reporting Person does not own any Senior notes. (b) The Reporting Person has sole power to vote and dispose of the 470000 shares held by him individually. (c) The following Shares were purchased in the open market during the prior 60 days (based on settlement date): Purchaser DATE Number of Shares AVERAGE PRICE Ziyad Binsalamah 05/15/2020 459807 $0.89 Ziyad Binsalamah 05/18/2020 10193 $0.895 The following Shares were sold in the open market during the prior 60 days (based on settlement date): None Seller DATE Number of shares PRICE (d) No person other than the Reporting Person is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Shares (e) Not applicable Item 6. Contracts, Arrangements, Understandings or relationships with Respect to Securities of the Issue There are no contracts, arrangements, understandings, or relationships between the Reporting Person and any other person with respect to any securities of the Issuer. Item 7. Material to Be Filed as Exhibits. None Item 8. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. 5/18/2020 Dated /s/ Signature Ziyad Binsalamah, MD Name/Title